In Vivo Assessment of Cortical Astrocyte Network Dysfunction During Autoimmune Demyelination: Correlation With Disease Severity
Journal of Neurochemistry · 2025
DOI: 10.1111/jnc.16305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von A Moreno-García und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain. Hauptthemen laut MEDLINE: Astrocytes, Encephalomyelitis, Autoimmune, Experimental, Somatosensory Cortex, Cerebral Cortex. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Conseil Régional Aquitaine, 'La Caixa' Foundation, Fondation Pour la Recherche Medicale.
Abstract (Originalsprache)
Cortical damage and dysfunction is a pathological hallmark of multiple sclerosis (MS) that correlates with the severity of physical and cognitive disability. Astrocytes participate in MS pathobiology through a variety of mechanisms, and abnormal astrocytic calcium signaling has been pointed as a pathogenic mechanism of cortical dysfunction in MS. However, in vivo evidence supporting deregulation of astrocyte calcium‐dependent mechanisms in cortical MS is still limited. Here, we applied fiber photometry to the longitudinal analysis of spontaneous and sensory‐evoked astrocyte network activity in the somatosensory cortex of mice in an experimental autoimmune encephalomyelitis (EAE). We found that freely moving EAE mice exhibit spontaneously occurring astrocyte calcium signals of increased duration and reduced amplitude. Concomitantly, cortical astrocytes in EAE mice responded to sensory stimulation with calcium events of decreased amplitude. The emergence of aberrant astrocyte calcium signals in the somatosensory cortex paralleled the onset of neurological symptomatology, and changes in the amplitude of both spontaneous and evoked responses were selectively correlated to the severity of neurological deficits. These results highlight the imbalance of astrocyte network activity in the brain cortex during autoimmune inflammation and further support the relevance of astrocyte‐based pathobiology as an underlying mechanism of cortical dysfunction in MS. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain.
- Achucarro Basque Center for Neuroscience, Leioa, Spain.
- Neuroinmunology Group, Biobizkaia Health Research Institute, Barakaldo, Spain.
- Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
- INSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
- University of Bordeaux, Bordeaux, France.
ORCID-Profile: S Mato
Förderung
- Conseil Régional Aquitaine
- 'La Caixa' Foundation
- Fondation Pour la Recherche Medicale
- European Research Council
- Ministerio de Ciencia e Innovacion
- Fondation Pour l'Aide à la Recherche sur la Sclérose en Plaques
- Instituto de Salud Carlos III
- Eusko Jaurlaritza
Zitieren
APA
Moreno-García, A., Serrat, R., Julio-Kalajzic, F., Bernal-Chico, A., Baraibar, A. M., Matute, C., Marsicano, G., & Mato, S. (2025). In Vivo Assessment of Cortical Astrocyte Network Dysfunction During Autoimmune Demyelination: Correlation With Disease Severity. Journal of Neurochemistry. https://doi.org/10.1111/jnc.16305
Vancouver
Moreno-García A, Serrat R, Julio-Kalajzic F, Bernal-Chico A, Baraibar AM, Matute C, et al. In Vivo Assessment of Cortical Astrocyte Network Dysfunction During Autoimmune Demyelination: Correlation With Disease Severity. Journal of Neurochemistry. 2025. doi:10.1111/jnc.16305
BibTeX
@article{MorenoGarca2025,
author = {Moreno-García, A and Serrat, R and Julio-Kalajzic, F and Bernal-Chico, A and Baraibar, A M and Matute, C and Marsicano, G and Mato, S},
title = {In Vivo Assessment of Cortical Astrocyte Network Dysfunction During Autoimmune Demyelination: Correlation With Disease Severity},
journal = {Journal of Neurochemistry},
year = {2025},
doi = {10.1111/jnc.16305}
}
EUVIMED